Veru Inc.
News
Veru to Present at the 2024 Cantor Global Healthcare Conference
Globe Newswire MIAMI, FL, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high...\n more…
Insiders Who Sold Veru Missed Out On 11% Stock Increase
Simply Wall St Last week, Veru Inc.'s (NASDAQ:VERU) stock jumped 11%, but insiders who sold US$334k worth of stock in over the past...\n more…
Veru: The biggest risk for the markets is to focus on just one data point
CNBC Television-YouTube Veru: The biggest risk for the markets is to focus on just one data point...\n more…
Equities Analysts Offer Predictions for Veru Inc.'s FY2024 Earnings (NASDAQ:VERU)
Ticker Report Veru Inc. (NASDAQ:VERU - Free Report) - B. Riley decreased their FY2024 earnings per share (EPS) estimates for shares of Veru in a report released on Monday, August 12th. B. Riley analyst W. Wood now...\n more…
Veru Inc. (VERU) Q3 2024 Earnings Call Transcript
Seeking Alpha: Transcripts Veru Inc. (VERU) Q3 2024 Earnings Call Transcript...\n more…
Veru Inc. (VERU) Reports Q3 Loss, Tops Revenue Estimates
Zacks Investment Research Veru Inc. (VERU) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to loss of $0.13 per share a year ago. These figures are...\n more…